M&A Deal Summary

ThermoGenesis Acquires CARTXpress Bio

On January 4, 2019, ThermoGenesis acquired medical products company CARTXpress Bio

Acquisition Highlights
  • This is ThermoGenesis’ 1st transaction in the Medical Products sector.
  • This is ThermoGenesis’ 1st transaction in Germany.

M&A Deal Summary

Date 2019-01-04
Target CARTXpress Bio
Sector Medical Products
Buyer(s) ThermoGenesis
Deal Type Add-on Acquisition

Target

CARTXpress Bio

Germany
CARTXpress Bio, Inc. is a developer and commercialization of automated medical devices and technologies for cell-based therapies, including stem cell banking, point-of-care applications, and large-scale cell manufacturing of immunotherapy drugs, such as chimeric antigen receptor (CAR) T cells.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

ThermoGenesis

Rancho Cordova, California, United States

Category Company
Founded 1986
Sector Medical Products
Employees25
Revenue 9M USD (2023)
DESCRIPTION

ThermoGenesis is a developer and manufacturer of automated blood processing systems and disposable products that enable the separation, preservation, and delivery of cell and tissue therapy products. ThermoGenesis was founded in 1986 and is based in Ranch Cordova, California.


DEAL STATS #
Overall 2 of 2
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
Country: Germany M&A 1 of 1
Year: 2019 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-10 SynGen

Sacramento, California, United States

SynGen, Inc. is a developer of products that utilize single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue. SynGen, Inc. was founded in 2007 and is based in Sacramento, California.

Buy -